Clinical Trial Update: Comparing Magnesium 2g Versus 4g Versus Placebo in the Incidence of Treating AFF RVR [Phase 3]

View source ↗

Summary

Phase 3 trial comparing 2 g and 4 g magnesium sulfate versus placebo for atrial fibrillation with rapid ventricular response is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Atrial Flutter

Drugs mentioned

• Magnesium sulfate (magnesium sulfate)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Tachycardia Atrial, Atrial Fibrillation | Phase 3 | Status: RECRUITING